RBMA President Kit Crancer said continued cuts will result in Medicare patients losing access to care when health systems and providers determine it is no longer economical.

Three months after an FDA panel declared a popular cold remedy no more effective than a sugar pill, a House oversight panel wants to ask FDA leadership a pointed question: What took you so long?

A lawsuit in federal court claims an AI algorithm used by the insurer systematically denied elderly patients’ claims for extended care.

The COVID-19 pandemic undid years and years of progress in terms of preventing CVD-related deaths. What can be done to help reverse this trend once and for all? 

The new-look syringes are causing significant issues when used with syringe infusion pumps. This is a Class I recall, which means the FDA believes the products “may cause serious injuries or death.”

He has agreed to pay an administrative fee of $1,100 within the next three months.

The civil case has a very high profile since the story unfolded in excruciating detail in a widely viewed documentary.

AHA members have voted to throw their full support behind the efforts to establish a new American Board of Cardiovascular Medicine.